Be Bio
Sue Bedard-Shurtleff is currently working as a Senior Associate Scientist at Be Biopharma, where tasks include IV dosing, tail bleeding, necropsy of mice, and IVIS imaging. Before their current role, Sue worked as a Principal Research Associate at Vedanta Biosciences, Inc., and as a Research Associate at Zikani Therapeutics. Sue also has experience at Charles River Laboratories, Alnylam Pharmaceuticals, Eisai US, and DaVinci Biomedical Research Products, Inc. Sue obtained a BS degree in Biology from UMass Boston in 2000.
This person is not in any offices
Be Bio
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.